牛牛AI助手已提取核心信息
Vertex Pharmaceuticals Inc. officer Amit Sachdev is set to sell 3,191 shares of common stock on 02/21/2024, as per the latest filing. The shares, valued at an aggregate market value of $1,345,868.07, were acquired on 02/20/2024 as performance shares, a form of compensation from the issuer. This transaction follows a recent history of sales by Sachdev, who has sold a total of 7,476 shares in the past three months, amounting to gross proceeds of $3,144,053.94.
Vertex Pharmaceuticals Inc. officer Amit Sachdev is set to sell 3,191 shares of common stock on 02/21/2024, as per the latest filing. The shares, valued at an aggregate market value of $1,345,868.07, were acquired on 02/20/2024 as performance shares, a form of compensation from the issuer. This transaction follows a recent history of sales by Sachdev, who has sold a total of 7,476 shares in the past three months, amounting to gross proceeds of $3,144,053.94.
最新文件显示，Vertex Pharmicals Inc.高管阿米特·萨赫杰夫定于2024年2月21日出售3,191股普通股。这些股票的总市值为1,345,868.07美元，于2024年2月20日作为高性能股票收购，这是发行人的一种补偿。该交易遵循了萨赫杰夫最近的销售历史，他在过去三个月中共出售了7,476股股票，总收益为3,144,053.94美元。
最新文件显示，Vertex Pharmicals Inc.高管阿米特·萨赫杰夫定于2024年2月21日出售3,191股普通股。这些股票的总市值为1,345,868.07美元，于2024年2月20日作为高性能股票收购，这是发行人的一种补偿。该交易遵循了萨赫杰夫最近的销售历史，他在过去三个月中共出售了7,476股股票，总收益为3,144,053.94美元。
有用
没用